Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)
Public ClinicalTrials.gov record NCT02125877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-label, Multicenter, Two Arm, Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)
Study identification
- NCT ID
- NCT02125877
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 173 participants
Conditions and interventions
Interventions
- Defearisox film-coated tablet Drug
- Deferasirox dispersible tablet Drug
Drug
Eligibility (public fields only)
- Age range
- 10 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2014
- Primary completion
- Feb 23, 2016
- Completion
- Feb 23, 2016
- Last update posted
- Jul 24, 2017
2014 – 2016
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital of Orange County Onc Dept | Orange | California | 92868-3874 | — |
| Lurie Children's Hospital of Chicago Onc Dept | Chicago | Illinois | 60611 | — |
| Children's Hospital Boston Department of Hematology | Boston | Massachusetts | 02115 | — |
| Weill Cornell Medical College-Cornell University Onc Dept | New York | New York | 10021 | — |
| Children's Hospital of Philadelphia Onc. Dept | Philadelphia | Pennsylvania | 19104-4399 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02125877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 24, 2017 · Synced Apr 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02125877 live on ClinicalTrials.gov.